MCID: VRL005
MIFTS: 42

Viral Pneumonia malady

Categories: Respiratory diseases, Infectious diseases

Aliases & Classifications for Viral Pneumonia

Aliases & Descriptions for Viral Pneumonia:

Name: Viral Pneumonia 12 14
Pneumonia, Viral 42 69

Classifications:



External Ids:

Disease Ontology 12 DOID:10533
ICD10 33 J12.9 J12
ICD9CM 35 480 480.9
MeSH 42 D011024
UMLS 69 C0032310

Summaries for Viral Pneumonia

Disease Ontology : 12 A pneumonia described as an inflammatory illness of the lung commonly caused by viruses such as influenza virus, parainfluenza, adenovirus, rhinovirus, herpes simplex virus, respiratory syncytial virus, hantavirus, and cytomegalovirus.

MalaCards based summary : Viral Pneumonia, also known as pneumonia, viral, is related to pneumonia and influenza. An important gene associated with Viral Pneumonia is CRP (C-Reactive Protein), and among its related pathways/superpathways are Innate Immune System and T cell receptor signaling pathway. The drugs Oseltamivir and Sulfamethoxazole have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and neutrophil.

Wikipedia : 71 Viral pneumonia is a pneumonia caused by a virus. Viruses are one of the two major causes of pneumonia,... more...

Related Diseases for Viral Pneumonia

Diseases in the Pneumonia family:

Viral Pneumonia

Diseases related to Viral Pneumonia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 79)
id Related Disease Score Top Affiliating Genes
1 pneumonia 11.3
2 influenza 11.2
3 lung disease, immunodeficiency, and chromosome breakage syndrome 10.8
4 coloboma of iris 10.3 CRP IL6
5 cutaneous sclerosis 10.3 CRP IL6
6 shoulder impingement syndrome 10.3 CRP IL6
7 unilateral multicystic dysplastic kidney 10.3 CRP IL6
8 neutrophilia, hereditary 10.3 CRP IL6
9 swine influenza 10.3 CRP IL6
10 cardiac tuberculosis 10.3 CRP IL6
11 laryngotracheoesophageal cleft type 2 10.3 CRP IL6
12 human immunodeficiency virus infectious disease 10.3 CRP IL6
13 secretory diarrhea myopathy and deafness 10.3 CRP IL6
14 hemangioma of spleen 10.3 CRP IL6
15 mixed eosinophil-basophil adenoma 10.3 CRP IL6
16 retinal degeneration 10.3 CRP IL6
17 joint disorders 10.3 CRP IL6
18 nodular nonsuppurative panniculitis 10.2 CRP IL6
19 toxic myocarditis 10.2 CRP IL6
20 cicatricial lagophthalmos 10.2 CRP IL6
21 multiple mitochondrial dysfunctions syndrome 10.2 CRP IL6
22 esotropia 10.2 CRP IL6
23 inhalation anthrax 10.2 CRP IL17A
24 benign neonatal seizures 10.2 CRP IL6
25 premature menopause 10.2 CRP IL6
26 reproductive system disease 10.2 IL17A IL6
27 lupus erythematosus 10.2 CRP IL6
28 fallopian tube serous adenocarcinoma 10.2 CRP IL6
29 smooth muscle tumor 10.2 IL17A IL6
30 trichomalacia 10.2 IL17A IL6
31 hyperlipoproteinemia type iv 10.2 CRP IL6
32 immune-complex glomerulonephritis 10.2 CR1 IL6
33 luxation of globe 10.2 CRP IL6
34 gastric dilatation 10.2 IL17A IL6
35 neuropathy 10.2 CRP IL6
36 mixed mineral dust pneumoconiosis 10.2 CRP IL6
37 choanal atresia, bilateral 10.2 IL17A IL6
38 autoimmune disease of central nervous system 10.2 CRP IL6
39 crohn's colitis 10.2 IL17A IL6
40 plummer's disease 10.1 CRP IL6
41 cataract, total congenital 10.1 CR1 CRP IL6
42 keratoconus 10.1 IL17A IL6
43 allergic bronchopulmonary aspergillosis 10.1 CRP IL6
44 follicular adenoma 10.1 CRP IL17A IL6
45 foodborne botulism 10.1 CRP IL17A IL6
46 bare lymphocyte syndrome, type i 10.1 CRP IL17A IL6
47 uterine ligament clear cell adenocarcinoma 10.1 CRP IL17A IL6
48 bone angioendothelial sarcoma 10.1 CRP IL17A IL6
49 acute chest syndrome 10.1 CRP IL17A IL6
50 histiocytosis 10.1 CRP IL17A IL6

Comorbidity relations with Viral Pneumonia via Phenotypic Disease Network (PDN):


Acute Cystitis Bronchitis
Chronic Myocardial Ischemia Deficiency Anemia
Familial Atrial Fibrillation Heart Disease
Hypothyroidism Ischemic Heart Disease
Postinflammatory Pulmonary Fibrosis Respiratory Failure

Graphical network of the top 20 diseases related to Viral Pneumonia:



Diseases related to Viral Pneumonia

Symptoms & Phenotypes for Viral Pneumonia

Drugs & Therapeutics for Viral Pneumonia

Drugs for Viral Pneumonia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 342)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Oseltamivir Approved Phase 4,Phase 3,Phase 1,Phase 2 204255-11-8, 196618-13-0 65028
2
Sulfamethoxazole Approved Phase 4,Phase 3,Phase 2,Phase 1 723-46-6 5329
3
Trimethoprim Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 738-70-5 5578
4
Azithromycin Approved Phase 4,Phase 3,Phase 2 83905-01-5 55185 53477736 447043
5
Ribavirin Approved Phase 4,Phase 3,Phase 1,Phase 2 36791-04-5 37542
6
Abacavir Approved, Investigational Phase 4 136470-78-5 65140 441300
7
Efavirenz Approved, Investigational Phase 4,Phase 3,Phase 1 154598-52-4 64139
8
Lamivudine Approved, Investigational Phase 4,Phase 3 134678-17-4 60825
9
Nevirapine Approved Phase 4 129618-40-2 4463
10
Zidovudine Approved Phase 4,Phase 3,Phase 2,Phase 1 30516-87-1 35370
11
Lopinavir Approved Phase 4 192725-17-0 92727
12
Ritonavir Approved, Investigational Phase 4,Phase 1 155213-67-5 392622
13
Mupirocin Approved, Investigational, Vet_approved Phase 4 12650-69-0 446596
14
Ganciclovir Approved, Investigational Phase 4,Phase 1,Phase 2 82410-32-0 3454
15
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613 2171
16
Atovaquone Approved Phase 4,Phase 3,Phase 2,Phase 1 95233-18-4 74989
17
Clindamycin Approved, Vet_approved Phase 4,Phase 3 18323-44-9 29029
18
Dapsone Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 80-08-0 2955
19
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
20
Pentamidine Approved Phase 4,Phase 3,Phase 2,Phase 1 100-33-4 4735
21
Prednisone Approved, Vet_approved Phase 4,Phase 1,Phase 2 53-03-2 5865
22
Primaquine Approved Phase 4,Phase 3 90-34-6 4908
23
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
24
Lenograstim Approved Phase 4 135968-09-1
25
Pentoxifylline Approved, Investigational Phase 4 6493-05-6 4740
26
Calcium carbonate Approved Phase 4 471-34-1
27
Peginterferon alfa-2b Approved Phase 4 99210-65-8, 215647-85-1
28
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 59-30-3 6037
29
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1 58-05-9 54575, 6560146 143
30 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
31 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
32 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
33 Antitubercular Agents Phase 4,Phase 3,Phase 2
34 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1
35 Heptavalent Pneumococcal Conjugate Vaccine Phase 4,Phase 3,Phase 2,Phase 1
36 Vaccines Phase 4,Phase 3,Phase 2,Phase 1
37 Antimalarials Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
38 Antiparasitic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
39 Antiprotozoal Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
40 Renal Agents Phase 4,Phase 3,Phase 2,Phase 1
41 Trimethoprim, Sulfamethoxazole Drug Combination Phase 4,Phase 3,Phase 2,Phase 1
42 Antibodies Phase 4,Phase 3,Phase 2,Phase 1
43 Immunoglobulins Phase 4,Phase 3,Phase 2,Phase 1
44 Gastrointestinal Agents Phase 4,Phase 3
45 Antimetabolites Phase 4,Phase 3,Phase 2,Phase 1
46 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 1,Phase 2
47 MF59 oil emulsion Phase 4
48 Anti-HIV Agents Phase 4,Phase 3,Phase 2,Phase 1
49 Anti-Retroviral Agents Phase 4,Phase 3,Phase 2,Phase 1
50
Bilirubin Phase 4 635-65-4 5280352

Interventional clinical trials:

(show top 50) (show all 307)
id Name Status NCT ID Phase
1 Duration of Antibiotic Therapy in Community - Acquired Pneumonia Unknown status NCT01492387 Phase 4
2 Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study Unknown status NCT00936013 Phase 4
3 7-valent Pneumococcal Conjugated Vaccination Unknown status NCT00885625 Phase 4
4 Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda Unknown status NCT00674921 Phase 4
5 Optimizing Influenza Vaccination in Surgical Oncology Patients Unknown status NCT01698177 Phase 4
6 High Dose Influenza Vaccine in Nursing Home Unknown status NCT01720277 Phase 4
7 Rapid Empiric Treatment With Oseltamivir Study (RETOS) Completed NCT01248715 Phase 4
8 Influenza Vaccine in HIV Infected Children Completed NCT00883012 Phase 4
9 Prevention of RSV Infections in Bone Marrow Transplant Recipients Completed NCT00001903 Phase 4
10 Intermittent Use of Aerosolized Ribavirin for Treatment of RSV Completed NCT00500578 Phase 4
11 Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections Completed NCT01779570 Phase 4
12 Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years Completed NCT02215863 Phase 4
13 Adjuvanted Influenza Vaccine in Stem Cell Transplant Completed NCT02560909 Phase 4
14 Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection Completed NCT00371878 Phase 4
15 Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067) Completed NCT00312858 Phase 4
16 Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa Completed NCT02028676 Phase 4
17 AZithromycin Against pLacebo in Exacerbations of Asthma Completed NCT01444469 Phase 4
18 Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa Completed NCT01088516 Phase 4
19 Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis Completed NCT00000816 Phase 4
20 Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children. Completed NCT01694108 Phase 4
21 Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance Completed NCT00137657 Phase 4
22 The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine Completed NCT02592486 Phase 4
23 Proteomic Profiling for Influenza Completed NCT00133588 Phase 4
24 Inactivated Influenza Vaccine Effectiveness in Tropical Africa Completed NCT00893906 Phase 4
25 Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events Completed NCT01417949 Phase 4
26 Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection Completed NCT00801879 Phase 4
27 Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults Completed NCT02062281 Phase 4
28 A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults Completed NCT00363870 Phase 4
29 Hutterite Influenza Prevention Study Completed NCT00877396 Phase 4
30 PTH - Preemptive Treatment for Herpesviridae Recruiting NCT02152358 Phase 4
31 G-CSF Plus NAC In Severe Alcoholic Hepatitis Recruiting NCT02971306 Phase 4
32 Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children Recruiting NCT02414399 Phase 4
33 Trial on the Ideal Duration of Oral Antibiotics in Children With Pneumonia Active, not recruiting NCT02258763 Phase 4
34 Live Versus Inactivated Influenza Vaccine Study in Hutterite Children Active, not recruiting NCT01653015 Phase 4
35 Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria Not yet recruiting NCT03087890 Phase 4
36 A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia Not yet recruiting NCT02972957 Phase 4
37 A Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With Influenza Not yet recruiting NCT02561169 Phase 4
38 Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED) Terminated NCT00687544 Phase 4
39 Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP) Withdrawn NCT00636935 Phase 4
40 Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial Completed NCT01868113 Phase 3
41 Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation Completed NCT00016081 Phase 3
42 Indiaclen Short Course Amoxycillin Therapy for Pneumonia With Wheeze Completed NCT00407394 Phase 3
43 Oseltamivir Randomised Controlled Efficacy Trial Completed NCT00707941 Phase 3
44 Evaluation of Respiratory Specimens for Bacterial and Viral Pathogens by Real-Time PCR Completed NCT00275691 Phase 2, Phase 3
45 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3
46 Maternal Vitamin D for Acute Respiratory Infections in Infancy Completed NCT02388516 Phase 3
47 Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. Completed NCT00829010 Phase 3
48 A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh Completed NCT01797029 Phase 3
49 Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection Completed NCT00098046 Phase 3
50 COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine Completed NCT00466947 Phase 3

Search NIH Clinical Center for Viral Pneumonia

Cochrane evidence based reviews: pneumonia, viral

Genetic Tests for Viral Pneumonia

Anatomical Context for Viral Pneumonia

MalaCards organs/tissues related to Viral Pneumonia:

39
Lung, Testes, Neutrophil, Endothelial, Monocytes, Kidney

Publications for Viral Pneumonia

Articles related to Viral Pneumonia:

(show top 50) (show all 140)
id Title Authors Year
1
Graft Loss and Clad Onset is Hastened by Viral Pneumonia After Lung Transplantation. ( 27467538 )
2016
2
Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia. ( 26934144 )
2016
3
Protective effects of Yinhuapinggan granule on mice with influenza viral pneumonia. ( 26655878 )
2016
4
Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults: An Observational Cohort Study. ( 26683973 )
2015
5
Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship. ( 26577540 )
2015
6
Review of Non-Bacterial Infections in Respiratory Medicine: Viral Pneumonia. ( 25957460 )
2015
7
CAUSATIVE AGENTS OF SEVERE COMMUNITY ACQUIRED VIRAL PNEUMONIA AMONG CHILDREN IN EASTERN THAILAND. ( 26867384 )
2015
8
The Serum Value of NO and IL-17 were Increased in Children with Influenza A Viral Pneumonia. ( 26642702 )
2015
9
Predictors of viral pneumonia in patients with community-acquired pneumonia. ( 25531901 )
2014
10
Viral pneumonia in severe respiratory failure. ( 24602995 )
2014
11
Aging exacerbates damage and delays repair of alveolar epithelia following influenza viral pneumonia. ( 25265939 )
2014
12
Combination therapy with hepatocyte growth factor and oseltamivir confers enhanced protection against influenza viral pneumonia. ( 24894172 )
2014
13
Middle East respiratory syndrome (MERS): a new zoonotic viral pneumonia. ( 25089913 )
2014
14
Epidemiology, etiology, x-ray features, importance of co-infections and clinical features of viral pneumonia in developing countries. ( 24410617 )
2014
15
Predictors of viral pneumonia: the need for viral testing in all patients hospitalized for nursing home-acquired pneumonia. ( 23441872 )
2013
16
Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia. ( 23344833 )
2013
17
Effect of the Haoqinqingdan decoction on damp-heat syndrome in rats with influenza viral pneumonia. ( 23790339 )
2013
18
Are statins beneficial for viral pneumonia? ( 23633609 )
2013
19
IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia. ( 24380719 )
2013
20
Influenza and endemic viral pneumonia. ( 24094391 )
2013
21
H7N9 viral pneumonia: asymmetric and irregular changes on computed tomography. ( 24342341 )
2013
22
A Patient who Survived Primary Seasonal Influenza Viral Pneumonia: Histologic Findings Obtained via Bronchoscopy. ( 24334588 )
2013
23
Gravity-dependent opacity in pure influenza viral pneumonia. ( 23370759 )
2013
24
Clinical significance of pleural effusion in the new influenza A (H1N1) viral pneumonia in children and adolescent. ( 22028096 )
2012
25
Radiological findings in 210 paediatric patients with viral pneumonia: a retrospective case study. ( 22514104 )
2012
26
Comparison of initial high resolution computed tomography features in viral pneumonia between metapneumovirus infection and severe acute respiratory syndrome. ( 21439753 )
2012
27
Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque. ( 22491448 )
2012
28
Alveolar epithelial cells orchestrate DC function in murine viral pneumonia. ( 22996662 )
2012
29
Acute kidney injury in critically ill patients with 2009 influenzaA A (H1N1) viral pneumonia: an observational study. ( 21394630 )
2011
30
Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice. ( 21383977 )
2011
31
Etiology and epidemiology of viral pneumonia among hospitalized children in rural Mozambique: a malaria endemic area with high prevalence of human immunodeficiency virus. ( 20805786 )
2011
32
Confirmed swine-origin influenza A(H1N1) viral pneumonia: computed tomographic findings in the immunocompetent and the immunocompromised. ( 21926856 )
2011
33
Con: corticosteroids are not indicated for treatment of acute lung injury from H1N1 viral pneumonia. ( 21531953 )
2011
34
H1N1: viral pneumonia as a cause of acute respiratory distress syndrome. ( 21157318 )
2011
35
ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia. ( 22072972 )
2011
36
Role of procalcitonin and C-reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia. ( 21668682 )
2011
37
Angioembolisation of pulmonary artery pseudoaneurysm arising in H1N1 influenza viral pneumonia. ( 21315652 )
2011
38
Viral pneumonia. ( 21435708 )
2011
39
Clinical characteristics and computed tomography findings in children with 2009 pandemic influenza A (H1N1) viral pneumonia. ( 20854219 )
2011
40
Imaging of pulmonary viral pneumonia. ( 21697307 )
2011
41
Epidemic viral pneumonia and other emerging pathogens. ( 21867815 )
2011
42
Mycoplasma pneumoniae pneumonia, bacterial pneumonia and viral pneumonia. ( 21140042 )
2010
43
Epidemic viral pneumonia. ( 20087179 )
2010
44
Impact of herpes simplex virus detection in respiratory specimens of patients with suspected viral pneumonia. ( 20589523 )
2010
45
Identification of adenovirus, influenza virus, parainfluenza virus, and respiratory syncytial virus by two kinds of multiplex polymerase chain reaction (PCR) and a shell vial culture in pediatric patients with viral pneumonia. ( 20635453 )
2010
46
Case of the month #165: Swine-origin influenza A (H1N1) viral pneumonia presenting as crazy-paving on computed tomography: case report and literature review. ( 20850032 )
2010
47
Evaluation by survival analysis on effect of traditional Chinese medicine in treating children with respiratory syncytial viral pneumonia of phlegm-heat blocking Fei syndrome. ( 19407945 )
2009
48
H1N1 pandemic flu found to cause viral pneumonia in severe cases, says WHO. ( 19843570 )
2009
49
Clinical review: primary influenza viral pneumonia. ( 20085663 )
2009
50
Viral pneumonia. ( 19276881 )
2009

Variations for Viral Pneumonia

Expression for Viral Pneumonia

Search GEO for disease gene expression data for Viral Pneumonia.

Pathways for Viral Pneumonia

GO Terms for Viral Pneumonia

Cellular components related to Viral Pneumonia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 8.8 FCRL6 IL17A IL6

Biological processes related to Viral Pneumonia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 defense response to virus GO:0051607 9.43 IFITM3 IL6 TLR3
2 positive regulation of interleukin-6 production GO:0032755 9.37 IL6 TLR3
3 acute-phase response GO:0006953 9.32 CRP IL6
4 inflammatory response GO:0006954 9.26 CRP IL17A IL6 TLR3
5 positive regulation of chemokine production GO:0032722 9.16 IL6 TLR3
6 negative regulation of lipid storage GO:0010888 8.62 CRP IL6

Sources for Viral Pneumonia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....